ולוויר

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Pieejams no:

RAFA LABORATORIES LTD

ATĶ kods:

J05AB11

Zāļu forma:

FILM COATED TABLETS

Ievadīšanas:

PER OS

Ražojis:

PHARMATHEN S.A., GREECE

Ārstniecības grupa:

VALACICLOVIR

Ārstēšanas norādes:

Valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. Valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established.Valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Autorizācija datums:

2013-05-01